BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 34406626)

  • 1. Impact of the COVID-19 Pandemic on Colorectal Cancer Screening: a Systematic Review.
    Mazidimoradi A; Tiznobaik A; Salehiniya H
    J Gastrointest Cancer; 2022 Sep; 53(3):730-744. PubMed ID: 34406626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the COVID-19 Pandemic on Colorectal Cancer Diagnosis and Treatment: a Systematic Review.
    Mazidimoradi A; Hadavandsiri F; Momenimovahed Z; Salehiniya H
    J Gastrointest Cancer; 2023 Mar; 54(1):171-187. PubMed ID: 34843058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the COVID-19 Pandemic on Fecal Immunochemical Testing, Colonoscopy Services, and Colorectal Neoplasia Detection in a Large United States Community-based Population.
    Lee JK; Lam AY; Jensen CD; Marks AR; Badalov J; Layefsky E; Kao K; Ho NJ; Schottinger JE; Ghai NR; Carlson CM; Halm EA; Green B; Li D; Corley DA; Levin TR
    Gastroenterology; 2022 Sep; 163(3):723-731.e6. PubMed ID: 35580655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of COVID-19 pandemic in the colorectal cancer prevention.
    Del Vecchio Blanco G; Calabrese E; Biancone L; Monteleone G; Paoluzi OA
    Int J Colorectal Dis; 2020 Oct; 35(10):1951-1954. PubMed ID: 32500432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of delaying colonoscopies during the COVID-19 pandemic on colorectal cancer detection and prevention.
    Holland J; Cwintal M; Rigas G; Pang AJ; Vasilevsky CA; Morin N; Ghitulescu G; Faria J; Boutros M
    Surg Endosc; 2022 Dec; 36(12):9364-9373. PubMed ID: 35428894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of COVID-19 pandemic on fecal immunochemical test screening uptake and compliance to diagnostic colonoscopy.
    Cheng SY; Chen CF; He HC; Chang LC; Hsu WF; Wu MS; Chiu HM
    J Gastroenterol Hepatol; 2021 Jun; 36(6):1614-1619. PubMed ID: 33217055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A delay in the diagnosis of colorectal cancer screened by fecal immunochemical tests during the COVID-19 pandemic: a longitudinal cohort study.
    Ishibashi F; Shida D; Suzuki S; Nagai M; Mochida K; Morishita T
    Int J Colorectal Dis; 2022 Dec; 37(12):2543-2546. PubMed ID: 36383225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study.
    van Wifferen F; de Jonge L; Worthington J; Greuter MJE; Lew JB; Nadeau C; van den Puttelaar R; Feletto E; Yong JHE; Lansdorp-Vogelaar I; Canfell K; Coupé VMH;
    J Med Screen; 2022 Jun; 29(2):72-83. PubMed ID: 35100894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global Impact of COVID-19 on Colorectal Cancer Screening: Current Insights and Future Directions.
    Kopel J; Ristic B; Brower GL; Goyal H
    Medicina (Kaunas); 2022 Jan; 58(1):. PubMed ID: 35056408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supply and quality of colonoscopy according to the characteristics of gastroenterologists in the French population-based colorectal-cancer screening program.
    Koïvogui A; Vincelet C; Abihsera G; Ait-Hadad H; Delattre H; Le Trung T; Bernoux A; Carroll R; Nicolet J
    World J Gastroenterol; 2023 Mar; 29(9):1492-1508. PubMed ID: 36998423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitigating the impact of COVID-19 on colorectal cancer screening: Organized service screening perspectives from the Asia-Pacific region.
    Chiu HM; Su CW; Hsu WF; Jen GH; Hsu CY; Chen SL; Chen HH
    Prev Med; 2021 Oct; 151():106622. PubMed ID: 34044024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The COVID-19 Pandemic: Identifying Adaptive Solutions for Colorectal Cancer Screening in Underserved Communities.
    Nodora JN; Gupta S; Howard N; Motadel K; Propst T; Rodriguez J; Schultz J; Velasquez S; Castañeda SF; Rabin B; Martínez ME
    J Natl Cancer Inst; 2021 Aug; 113(8):962-968. PubMed ID: 32780851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term impact of the COVID-19 pandemic on a population-based screening program for colorectal cancer in Catalonia (Spain).
    Vives N; Binefa G; Vidal C; Milà N; Muñoz R; Guardiola V; Rial O; Garcia M
    Prev Med; 2022 Feb; 155():106929. PubMed ID: 34954239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The national FIT-based colorectal cancer screening program in the Netherlands during the COVID-19 pandemic.
    Kortlever TL; de Jonge L; Wisse PHA; Seriese I; Otto-Terlouw P; van Leerdam ME; Spaander MCW; Dekker E; Lansdorp-Vogelaar I
    Prev Med; 2021 Oct; 151():106643. PubMed ID: 34217421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prioritisation by FIT to mitigate the impact of delays in the 2-week wait colorectal cancer referral pathway during the COVID-19 pandemic: a UK modelling study.
    Loveday C; Sud A; Jones ME; Broggio J; Scott S; Gronthound F; Torr B; Garrett A; Nicol DL; Jhanji S; Boyce SA; Williams M; Barry C; Riboli E; Kipps E; McFerran E; Muller DC; Lyratzopoulos G; Lawler M; Abulafi M; Houlston RS; Turnbull C
    Gut; 2021 Jun; 70(6):1053-1060. PubMed ID: 32855306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of SARS-CoV-2 Pandemic on Colorectal Cancer Screening Delay: Effect on Stage Shift and Increased Mortality.
    Ricciardiello L; Ferrari C; Cameletti M; Gaianill F; Buttitta F; Bazzoli F; Luigi de'Angelis G; Malesci A; Laghi L
    Clin Gastroenterol Hepatol; 2021 Jul; 19(7):1410-1417.e9. PubMed ID: 32898707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed Colorectal Cancer Diagnosis during the COVID-19 Pandemic in Alberta: A Framework for Analyzing Barriers to Diagnosis and Generating Evidence to Support Health System Changes Aimed at Reducing Time to Diagnosis.
    Walker E; Fu Y; Sadowski DC; Stewart D; Tang P; Kaposhi B; Chappell H; Robson P; Veldhuyzen van Zanten S
    Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling the impacts of COVID-19 pandemic on the quality of population-based colorectal cancer screening.
    Jen GH; Yen AM; Hsu CY; Chiu HM; Chen SL; Chen TH
    Prev Med; 2021 Oct; 151():106597. PubMed ID: 34217416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the SARS-CoV-2 pandemic on colorectal cancer diagnosis and prognosis.
    Medina-Prado L; Sala-Miquel N; Aicart-Ramos M; López-Cardona J; Ponce-Romero M; Ortíz O; Pellisé M; Aguilera L; Díez-Redondo P; Núñez-Rodríguez H; Seoane A; Domper-Arnal MJ; Borao-Laguna C; González-Bernardo Ó; Suárez A; Muñoz-Tornero M; Bustamante-Balén M; Soutullo-Castiñeiras C; Balleste-Peris B; Esteban P; Jiménez-Gómez M; Albert M; Lucas J; Valdivieso-Cortázar E; López-Serrano A; Solano M; Tejedor-Tejada J; Trelles M; Zapater P; Jover R
    Cancer Med; 2024 Mar; 13(5):e6923. PubMed ID: 38491824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.